Activation of Hif1α by the Prolylhydroxylase Inhibitor Dimethyoxalyglycine Decreases RadiosensitivityMarina K. Ayrapetov, Brendan D. Price|PLoS ONE|2011Cited by 41
The Targeted Degradation of BRAF V600E Reveals the Mechanisms of Resistance to BRAF-Targeted Treatments in Colorectal Cancer CellsAbygail G. Chapdelaine, Marina K. Ayrapetov|Cancers|2023Cited by 10